TradingView Earnings
Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 1–36
- Headlines
- 145
- Sources here
- 15
- Companies here
- 16
Chronological news
Latest headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes
LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes …
Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia
A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. The study will contribute to a better understanding of preventive healthcare and …
ImmuPharma, ValiRx, Tertiary Minerals, Caledonia Mining, Sintana Energy - Small Cap Snapshot
ImmuPharma PLC (AIM:IMM, FRA:25I) has signed up Kymos Group as its bioanalytical partner for diabetes drug Kapiglucagon. That completes the outsourced team needed to file for human trials in the US. ValiRx PLC (AIM:VAL, FRA:EAJF) is set to get a second European patent for …
Sharemaestro market context Price below Trend Line 52 weeks +147.2%AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. SOPHiA GENETICS and AstraZeneca (LSE:AZN) have entered a global partnership to develop and launch two decentralized companion diagnostics in precision oncology. The multi-year collaboration focuses on clinical …